Disease regression was associated with improved recurrence-free survival and overall survival among certain patients with stage 1 and 2 cutaneous melanomas, according to a study.
Disease regression was associated with improved recurrence-free survival and overall survival among certain patients with stage 1 and 2 cutaneous melanomas, according to a study.
Posted in Melanoma News, Health Professionals, Of Interest
Scientists from the University of Granada and GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), in a study led by Juan Carlos Rodríguez-Manzaneque, have demonstrated the significant role of a protein called ADAMTS1 in uveal melanoma, one of the rarest and most aggressive cancers that exist, which develops in the eye.
Posted in Melanoma News, Health Professionals, Of Interest
A new paper from the McArthur & Sheppard Laboratory, by Emily Lelliott et. al.
Posted in Melanoma News, Health Professionals, Of Interest, Publications, Scientific Publications
Overall cancer mortality rates in the United States continued to drop precipitously, falling by 2.4% from 2017-2018, according to the American Cancer Society’s latest Cancer Statistics report.
Posted in Melanoma News, Health Professionals, Of Interest